title: Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran.
abstract: OBJECTIVE
  A global distribution has been shown for hepatitis E virus (HEV) infection. Although the fecal-oral was considered as the primary infection route, there is controversial evidence for increased risk of the infection and consequent problems in patients on maintenance hemodialysis (HD) with suppressed immunity. The aim is to find if the prevalence of anti-HEV IgG, in patients with maintenance HD is higher than normal population in southwest of Iran.
  
  
  METHODS
  During November and December 2010, in a cross-sectional study we compared the seroprevalence of HEV among 80 patients with maintenance HD and 276 healthy individuals from Jahrom and Shiraz, Southwest of Iran. In addition to the clinical and laboratory records, serum samples were tested for the presence of IgG anti-HEV antibody by enzyme immunoassay (ELISA) test. The Chi-square, the Student's 't' and Fisher's exact tests were used for the statistical analysis.
  
  
  RESULTS
  ELISA tests detected anti-HEV antibody in five males of the patients (6.3%) and in eight of the healthy controls (2.9%, 6 males and 2 female) which statistically were not different. The mean levels of the aspartate aminotransferase and the alanine aminotransferase in the sera of the patients were 19.96±11.08U/L and 23.93±14.26 IU/L, respectively. However, no one of the individuals with positive anti-HEV antibody showed elevated liver enzymes. Moreover, there was not a significant association between positive anti-HEV antibody result, age and the history of the hemodialysis.
  
  
  CONCLUSIONS
  We did not observe statistically significant higher anti-HEV prevalence among patients with chronic HD; however, more safety precaution is needed to keep HD patients from the risk of possible exposure to HEV infection.
authors.affiliation: Department of Pediatrics, Hematology Research Centre, School of Medicine, University of Medical Sciences, Jahrom, Iran.
authors.forename: Omid R
authors.initials: OR
authors.lastname: Zekavat
authors.forename: Alireza
authors.initials: A
authors.lastname: Makarem
authors.forename: Mohammad Y
authors.initials: MY
authors.lastname: Karami
authors.forename: Aida
authors.initials: A
authors.lastname: Amanat
authors.forename: Maesoomeh
authors.initials: M
authors.lastname: Mohandes
authors.forename: Mojtaba
authors.initials: M
authors.lastname: Habibagahi
keywords: ELISA; Hepatitis E virus; hemodialysis; iran; seroprevalence
references.citation: J Viral Hepat. 2011 Oct;18(10):e603-8
references.pmid: 21914082
references.citation: Nephrol Dial Transplant. 2011 Aug;26(8):2648-56
references.pmid: 21273235
references.citation: Vox Sang. 2000;79(2):72-4
references.pmid: 11054043
references.citation: East Mediterr Health J. 2008 Jan-Feb;14(1):157-62
references.pmid: 18557463
references.citation: BMC Infect Dis. 2008 May 08;8:61
references.pmid: 18462508
references.citation: Indian J Med Microbiol. 2011 Oct-Dec;29(4):353-8
references.pmid: 22120793
references.citation: Intervirology. 2008;51(1):21-5
references.pmid: 18309245
references.citation: Nephrol Dial Transplant. 1997 Jan;12(1):133-6
references.pmid: 9027787
references.citation: Nephron Clin Pract. 2005;99(4):c122-7
references.pmid: 15722643
references.citation: Int J Infect Dis. 2008 Jul;12(4):387-90
references.pmid: 18063401
references.citation: Lancet. 1993 Jun 19;341(8860):1561-2
references.pmid: 8099641
references.citation: Lancet. 1994 Sep 10;344(8924):746
references.pmid: 7802786
references.citation: J Clin Microbiol. 2002 Sep;40(9):3209-18
references.pmid: 12202555
references.citation: J Med Virol. 2004 Dec;74(4):563-72
references.pmid: 15484278
references.citation: Rev Med Virol. 2006 Jan-Feb;16(1):5-36
references.pmid: 16175650
references.citation: Intervirology. 2007;50(4):281-6
references.pmid: 17570930
references.citation: J Viral Hepat. 2011 Oct;18(10):e583-90
references.pmid: 21914080
references.citation: Int J Infect Dis. 2009 Jan;13(1):67-71
references.pmid: 18599335
references.citation: Lancet. 1993 Feb 6;341(8841):378
references.pmid: 8094150
references.citation: N Engl J Med. 2008 Feb 21;358(8):859-60
references.pmid: 18287615
references.citation: Clin Infect Dis. 2003 Jan 1;36(1):29-33
references.pmid: 12491198
references.citation: Dig Liver Dis. 2011 Dec;43(12):996-1000
references.pmid: 21880560
references.citation: Clin Vaccine Immunol. 2006 Dec;13(12):1328-32
references.pmid: 17050741
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12986-91
references.pmid: 19620712
references.citation: Am J Trop Med Hyg. 1997 Jul;57(1):60-1
references.pmid: 9242319
references.citation: Lancet. 1994 Sep 10;344(8924):746-7
references.pmid: 7915787
references.citation: Am J Nephrol. 2010;31(5):398-407
references.pmid: 20357431
references.citation: Transfusion. 1998 Jun;38(6):589-95
references.pmid: 9661693
references.citation: Asian J Transfus Sci. 2011 Jul;5(2):136-9
references.pmid: 21897591
references.citation: BMC Infect Dis. 2005 May 17;5:36
references.pmid: 15904504
references.citation: J Med Virol. 2010 Nov;82(11):1899-902
references.pmid: 20872716
references.citation: J Biosci. 2008 Nov;33(4):451-64
references.pmid: 19208971
references.citation: J Viral Hepat. 2007 Feb;14(2):140-6
references.pmid: 17244254
references.citation: East Mediterr Health J. 2009 Jan-Feb;15(1):136-42
references.pmid: 19469436
references.citation: J Viral Hepat. 2002 Sep;9(5):390-2
references.pmid: 12225335
references.citation: Hippokratia. 2011 Apr;15(2):120-6
references.pmid: 22110292
references.citation: Southeast Asian J Trop Med Public Health. 2006 Jan;37(1):90-5
references.pmid: 16771218